le Roux CW, Steen O, Luca KJ, Startseva E, Unseld A, Hennige AM (2024) Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
It's not a sleeping pill, and it's not a stimulant
At TrimRx, we understand that questions about everyday medications like ibuprofen are part of the process
1. Tone refinement (clarity signal): Niacinamide supports a more even-looking surface and helps reduce the look of tone irregularities that create visual distraction
Our estimate of 23% households using GLP-1 annually correlates to an underlying individual usage rate of ~10-14%, which is aligned with estimates we see from other independent sources